
Serena Williams’ Tennis Comeback and Zepbound: What’s Confirmed, What Isn’t, and What WADA Actually Says
Serena Williams disclosed GLP-1 treatment and a commercial Ro relationship in 2025, then returned to professional tennis in 2026. No cited official source confirms current Zepbound use. Here is the dated evidence and the difference between WADA monitoring and prohibition.